Predicting Benefit From Evolocumab Therapy in Patients With Atherosclerotic Disease Using a Genetic Risk Score Results From the FOURIER Trial

Marston, NA; Kamanu, FK; Nordio, F; Gurmu, Y; Roselli, C; Sever, PS; Pedersen, TR; Keech, AC; Wang, H; Pineda, AL; Giugliano, RP; Lubitz, SA; Ellinor, PT; Sabatine, MS; Ruff, CT

Ruff, CT (corresponding author), Brigham & Womens Hosp, Hale Bldg Transformat Med,60 Fenwood Rd, Boston, MA 02115 USA.

CIRCULATION, 2020; 141 (8): 616

Abstract

Background: The ability of a genetic risk score to predict risk in established cardiovascular disease and identify individuals who derive greater bene......

Full Text Link